Professor David Henshall and colleagues from RCSI have published new findings identifying a potential disease-modifying drug for epilepsy. Currently, no epilepsy drug offers "disease modifying" effects, meaning that if a patient stops taking the drug their seizures will return.
New UK guidelines produced by the Royal College of Obstetricians and Gynaecologists, recommend women seek advice well before pregnancy on their care.
Medtronic plc, a medical device company based in Dublin, announced on Friday that the US Food and Drug Administration (FDA) has approved the testing of its Visualase(TM) laser ablation system in a clinical trial.
Sleep and rest are important for everyone, without it the risk of a range of health issues, including heart disease, stroke, depression, diabetes, hypertension, and cancer rise.
Sanofi and the HPRA have updated & redistributed important information booklets on the use of valproate (e.g. Epilim) in women and the risks associated with the drug in pregnancy.
A new study conducted by Maastricht University indicates that the ketogenic diet may help behavioural and mental processes in young people with refractory epilepsy..
A new EU research programme to develop ways of monitoring three main central nervous system conditions, epilepsy, multiple sclerosis (MS) and depressive disorder, using wearable devices and smartphones has been launched.
A new study just published indicates that children with Type 1 Diabetes are almost 3 times more likely to develop epilepsy as children without Type 1 Diabetes.
Despite recent advances in the understanding and treatment of epilepsy, up to 30% of people living with the condition do not respond to existing anti-epileptic drugs (AEDs) and continue to experience regular, debilitating and potentially life-threatening seizures.
Researchers at Case Western Reserve University in Ohio have discovered that, even in the absence of seizures, people with generalised epilepsy have differences in their heart activity compared to the average person.